Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis

被引:178
作者
Cepok, S
Jacobsen, M
Schock, S
Omer, B
Jaekel, S
Böddeker, I
Oertel, WH
Sommer, N
Hemmer, B
机构
[1] Univ Marburg, Dept Neurol, Clin Neuroimmunol Grp, D-35033 Marburg, Germany
[2] Univ Marburg, Inst Med Biometry & Epidemiol, D-35033 Marburg, Germany
关键词
multiple sclerosis; cerebrospinal fluid; B cells; monocytes;
D O I
10.1093/brain/124.11.2169
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Multiple sclerosis is a chronic inflammatory and demyelinating disease of the CNS with, as yet, an unknown aetiology. Temporal profile, intensity and treatment responses are highly variable in multiple sclerosis suggesting pathogenetic heterogeneity. This hypothesis has been supported by histopathological studies disclosing at least four different subtypes of acute demyelinating lesions. Although stratification of multiple sclerosis patients into these categories would be extremely helpful for clinical studies, this approach is impractical as it requires brain biopsy. In this study we investigated CSF cytology from 60 multiple sclerosis patients by flow cytometry. We identified different patterns of CSF cytology, which were independent of immunological parameters in the peripheral blood. The most variable CSF parameter was the B cell to monocyte ratio, which remained stable during different phases of disease in selected patients. The ratio correlated with disease progression but not with disability or disease duration in a retrospective, consecutive analysis. A high ratio (predominance of B cells) was associated with more rapid disease progression, whereas a low ratio (predominance of monocytes) was found in patients with slower progression. Our study demonstrates the existence and potential clinical relevance of different CSF cytology patterns. We hypothesize that CSF cytology patterns may reflect the heterogeneity in the pathogenesis of multiple sclerosis.
引用
收藏
页码:2169 / 2176
页数:8
相关论文
共 50 条
  • [41] Cerebrospinal fluid diagnostics in multiple sclerosis
    Ruprecht, K.
    Tumani, H.
    NERVENARZT, 2016, 87 (12): : 1282 - 1287
  • [42] Cerebrospinal fluid somatostatin, mood, and cognition in multiple sclerosis
    Roca, CA
    Su, TP
    Elpern, S
    McFarland, H
    Rubinow, DR
    BIOLOGICAL PSYCHIATRY, 1999, 46 (04) : 551 - 556
  • [43] Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis
    Augutis, Kristin
    Axelsson, Markus
    Portelius, Erik
    Brinkmalm, Gunnar
    Andreasson, Ulf
    Gustavsson, Mikael K.
    Malmestrom, Clas
    Lycke, Jan
    Blennow, Kaj
    Zetterberg, Henrik
    Mattsson, Niklas
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (05) : 543 - 552
  • [44] Prognostic value of cerebrospinal fluid glutamate in multiple sclerosis
    Pappolla, Agustin
    Sanchez, Francisco
    Patrucco, Liliana
    Varela, Lucia
    Castanares, Clara
    Lopez, Pablo H.
    Cristiano, Edgardo
    Rojas, Juan, I
    MEDICINA-BUENOS AIRES, 2021, 81 (05) : 774 - 779
  • [45] Cerebrospinal fluid nitrate levels in patients with multiple sclerosis
    de Bustos, F
    Navarro, JA
    de Andrés, C
    Molina, JA
    Jiménez-Jiménez, FJ
    Ortí-Pareja, M
    Gasalla, T
    Tallón-Barranco, A
    Martínez-Salio, A
    Arenas, J
    EUROPEAN NEUROLOGY, 1999, 41 (01) : 44 - 47
  • [46] Increased cerebrospinal fluid tau protein in multiple sclerosis
    Kapaki, E
    Paraskevas, GP
    Michalopoulou, M
    Kilidireas, K
    EUROPEAN NEUROLOGY, 2000, 43 (04) : 228 - 232
  • [47] Cerebrospinal fluid concentrations of ghrelin in patients with multiple sclerosis
    Unger, Marcus M.
    Oertel, Wolfgang H.
    Tackenberg, Bjorn
    NEUROENDOCRINOLOGY LETTERS, 2013, 34 (01) : 14 - 17
  • [48] Cerebrospinal fluid lactate and glutamine are reduced in multiple sclerosis
    Aasly, J
    Garseth, M
    Sonnewald, U
    Zwart, JA
    White, LR
    Unsgard, G
    ACTA NEUROLOGICA SCANDINAVICA, 1997, 95 (01): : 9 - 12
  • [49] Multiplex assessment of cerebrospinal fluid biomarkers in multiple sclerosis
    Mahler, Mie Reith
    Sondergaard, Helle Bach
    Buhelt, Sophie
    von Essen, Marina Rode
    Christensen, Jeppe Romme
    Enevold, Christian
    Sellebjerg, Finn
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 45
  • [50] Molecular biomarkers in cerebrospinal fluid of multiple sclerosis patients
    Fitzner, Brit
    Hecker, Michael
    Zettl, Uwe Klaus
    AUTOIMMUNITY REVIEWS, 2015, 14 (10) : 903 - 913